Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has received a harsher reprimand from the U.S. FDA, though not for the sorts of ...
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical ...
India's Alembic Pharma posts quarterly profit rise on strong generics demand India's Alembic Pharmaceuticals on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for ...
Alembic Pharmaceuticals on Monday said the U.S. Food and Drug Administration (U.S. FDA) has issued a warning letter to the clinical Investigator associated with a bioequivalence study conducted at the ...
Aug 06, 2026, 11:26 PM IST IST Alembic Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Aug 06, 2026, 12:26 AM IST IST Alembic Pharma. - Shareholder Meeting / Postal Ballot-Outcome ...
Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical ...
Alembic Pharmaceuticals Ltd (ALEM) has delivered a -12.58% change over the past year, with a 52-week range between 635.80 and 1,002.00. What Is the Average Daily Trading Volume of Alembic ...
Track the company's earnings performance through key income statement metrics such as revenue, net profit, and operating income. Analyse trends in income growth, expenses, profitability, and earnings ...
Alembic Pharmaceuticals Limited is a leading research-driven, integrated pharmaceutical enterprise specialising in the development and manufacturing of generic formulations across diverse therapeutic ...
Drug firm Alembic Pharmaceuticals Ltd on Monday (July 13) said it has been informed that the USFDA has issued a warning letter to the clinical investigator associated with a bioequivalence study ...
Shares of Alembic Pharmaceuticals Ltd. are trading lower by 2% on Tuesday, July 14, after the company disclosed that the US Food and Drug Administration (USFDA) has issued a warning letter to a ...